Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country.
Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...
In June 2025, the US Food and Drug Administration (FDA) issued a final guidance titled Cybersecurity in Medical Devices: ...
Founded by former Illumina, Grail and Google leaders, Hepta is applying the technological, genomic and commercialization expertise that made liquid biopsy possible in oncology to the far larger field ...
At the booth of Gilead Sciences, Lenacapavir, to be used as the world's only twice-yearly, long-acting injectable for HIV ...
According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass USD 15.62 billion by 2030, growing at a CAGR of 12.42% ...
According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass ...
The Chinese Ministry of Commerce (MOFCOM) today announced it will lift the export ban on Illumina, Inc. (NASDAQ: ILMN), which had been in place since March 4, 2025. While the ban will be lifted on ...
Regulatory mechanisms governing stem cell quiescence in glandular organs remain ill-defined. Here, multi-omics profiling ...
News-Medical.Net on MSN
SPT Labtech and Alithea Genomics collaborate to automate ultra sensitive single-cell transcriptomic workflows
SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and ...
Touchlight has expanded its mbDNA platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback